This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): Conjugated estrogens and medroxyprogesterone acetate
Description: Prempro is an estrogen and progesterone combination containing conjugated estrogens and medroxyprogesterone acetate.
Deal Structure: Prempro was originally developed by Wyeth.
In January 2009, Pfizer and Wyeth announced that they entered into a definitive merger agreement under which Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at $50.19 per share, or a total of approximately $68 billion. In October 2009, Pfizer completed its acquisition of Wyeth.
Pink Sheet Low-Dose Prempro Boosts Premarin Family
Pink Sheet In Brief: Wyeth-Ayerst Prempro
Additional information available to subscribers only: